Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.cell.2021.03.052 http://scihub22266oqcxt.onion/10.1016/j.cell.2021.03.052 33861950!8009040!33861950     free     free     free Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Cell 2021 ; 184 (10): 2587-2594.e7 Nephropedia Template TP {{tp|p=33861950|t=2021. Emergence and rapid transmission of SARS-CoV-2 B 1 1 7 in the United States |pdf=|usr=}}{{33861950}} gab.com Text Emergence and rapid transmission of SARS-CoV-2 B 1 1 7 in the United States JO: Cell http://www.kidney.de/pget.php?&tw=1&pmid=33861950 #FOAvip The highly transmissible B.1.1.7 variant of SARS-CoV-2, first identified in the United Kingdom, has gained a foothold across the world. Using S gene target failure (SGTF) and SARS-CoV-2 genomic sequencing, we investigated the prevalence and dynamics of this variant in the United States (US), tracking it back to its early emergence. We found that, while the fraction of B.1.1.7 varied by state, the variant increased at a logistic rate with a roughly weekly doubling rate and an increased transmission of 40%-50%. We revealed several independent introductions of B.1.1.7 into the US as early as late November 2020, with community transmission spreading it to most states within months. We show that the US is on a similar trajectory as other countries where B.1.1.7 became dominant, requiring immediate and decisive action to minimize COVID-19 morbidity and mortality. Twit Text FOAVip Emergence and rapid transmission of SARS-CoV-2 B 1 1 7 in the United States ????Cell http://www.kidney.de/pget.php?&tw=1&pmid=33861950 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33861950 #FOAvip English Wikipedia <ref>{{Cite pmid|33861950}}</ref> Emergence and rapid transmission of SARS-CoV-2 B 1 1 7 in the United States #MMPMID33861950 Washington NL; Gangavarapu K; Zeller M; Bolze A; Cirulli ET; Schiabor Barrett KM; Larsen BB; Anderson C; White S; Cassens T; Jacobs S; Levan G; Nguyen J; Ramirez JM 3rd; Rivera-Garcia C; Sandoval E; Wang X; Wong D; Spencer E; Robles-Sikisaka R; Kurzban E; Hughes LD; Deng X; Wang C; Servellita V; Valentine H; De Hoff P; Seaver P; Sathe S; Gietzen K; Sickler B; Antico J; Hoon K; Liu J; Harding A; Bakhtar O; Basler T; Austin B; MacCannell D; Isaksson M; Febbo PG; Becker D; Laurent M; McDonald E; Yeo GW; Knight R; Laurent LC; de Feo E; Worobey M; Chiu CY; Suchard MA; Lu JT; Lee W; Andersen KG Cell 2021[May]; 184 (10): 2587-2594.e7 PMID33861950show ga The highly transmissible B.1.1.7 variant of SARS-CoV-2, first identified in the United Kingdom, has gained a foothold across the world. Using S gene target failure (SGTF) and SARS-CoV-2 genomic sequencing, we investigated the prevalence and dynamics of this variant in the United States (US), tracking it back to its early emergence. We found that, while the fraction of B.1.1.7 varied by state, the variant increased at a logistic rate with a roughly weekly doubling rate and an increased transmission of 40%-50%. We revealed several independent introductions of B.1.1.7 into the US as early as late November 2020, with community transmission spreading it to most states within months. We show that the US is on a similar trajectory as other countries where B.1.1.7 became dominant, requiring immediate and decisive action to minimize COVID-19 morbidity and mortality. |*COVID-19/genetics/mortality/transmission[MESH] |*Models, Biological[MESH] |*SARS-CoV-2/genetics/metabolism/pathogenicity[MESH] |Female[MESH] |Humans[MESH] |Male[MESH]Emergence and rapid transmission of SARS-CoV-2 B 1 1 7 in the United S(epmc).pdf DeepDyve Pubget Overpricing